Related Experiment Video
Updated: Sep 25, 2025

09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.4K
Trans-urocanic acid facilitates spatial memory, implications for Alzheimer's disease
Xu-Dong Yu1, Ao Li1, Xiao-Ya Li2
1School of Basic Medical Sciences, Shaoyang University, 422000, Shaoyang, China.
Physiology & Behavior
|May 1, 2022
Summary
Trans-urocanic acid (trans-UCA) enhances spatial memory performance in behavioral tests. Network pharmacology identified key signaling pathways, suggesting therapeutic potential for conditions like Alzheimer's disease (AD).
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Trans-urocanic acid (trans-UCA), found in the brain, has known roles in non-spatial memory.
- Its specific impact on spatial memory and underlying mechanisms are not well understood.
Purpose of the Study:
- To investigate the role of trans-UCA in spatial memory.
- To predict the molecular mechanisms of trans-UCA's effects using network pharmacology.
Main Methods:
- Network pharmacology strategy, including database analysis and Venn diagrams.
- Behavioral testing: Y-maze and object location recognition (OLR) tasks.
- Protein-protein interaction (PPI) network analysis, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
Main Results:
- Identified 40 intersecting targets between trans-UCA and spatial memory.
- Trans-UCA significantly improved spatial working memory and spatial recognition memory (acquisition, consolidation, retrieval).
- Key pathways involved include insulin, MAPK, NF-κB signaling, serotonergic synapse, and arginine/proline metabolism.
Conclusions:
- Trans-urocanic acid (trans-UCA) facilitates spatial memory functions.
- The study suggests potential therapeutic applications for Alzheimer's disease (AD).
- Predicted molecular mechanisms require further experimental validation.
Related Concept Videos
Alzheimer's Disease: Overview
693
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
693
Alzheimer's Disease: Treatment
272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272
Role of Neurotransmitters in Memory
1.0K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.0K
Role of Hippocampus in Memory
594
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
594

